Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.025 CAD
−10.69 M CAD
41.96 M CAD
389.43 M
About MEDIPHARM LABS CORP
Sector
Industry
CEO
David A. Pidduck
Website
Headquarters
Barrie
Founded
2015
FIGI
BBG00K17KSD0
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. It focuses on the downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. It supplies raw materials, formulations, processing, and packaging for the creation of ready-to-sell derivative products. The company was founded by Patrick McCutcheon and Keith Strachan in 2015 and is headquartered in Barrie, Canada.
Patience I think medipharm is a decent company they have a lot going for them and they are on the verge of profitablity, and when call you have Pierre Poilievre in office in Canada all Canadian stocks that aren't terrible are going to be bullish for sure. My average buy in is 7 cents Canadian and if your a U
GOLDEN CROSSToday, Medipharm Labs's 50-day moving average line crossed above its 200-day moving average line, forming a GOLDEN CROSS, a STRONG BULLISH signal.
Today, the stock went up by 13.33% on more than 4 times average daily volume.
Tradingview's technical analysis summary is BUY:
www.tradingview.com
GL
IMMINENT GOLDEN CROSSMedipharm Labs's 50-day and 200-day moving average lines are a quarter of a penny from forming a GOLDEN CROSS, a strong BULLISH signal.
Extrapolation of these lines strongly suggests that they might form a GOLDEN CROSS this coming week.
Also, the Accumulation/Distribution indicator has clearly bee
From 5.50 to under 0.50 stock, would you buy ?Read latest news here , here
Think about stock investment like America got Talent show. If a stock has good potential but lack coverage by analysts, institutional buyers, media coverage, etc, it would take some time for investors to take notice. The show or the analysts coverage, etc are the p
Medif I currently do not own this stock but am looking to purchase soon for the potential run. I am no expert do your own reasearch , but im glad to share my opinion and input and learn together. Good Luck everyone! if you want to play it safe you can also ride it up to the 200dma if you keep an eye on it
CLIMBING ABOVE 50-DAY MOVING AVERAGE LINEToday Medipharm Labs climbed above its 50-day moving average line, a strong BULLISH signal. It did so by going up by 27.12% on more than 3 times average daily volume. In the process, it filled a major gap.
TradingView's technical analysis summary is BUY:
www.tradingview.com
This stock has a con
This may be the bottom of LABSLooking at the weekly we can see there is a bullish divergence and there seems to be another one forming on the daily. Looks like a great recipe for a technical bottom. Of course this trade will largely depend on the earnings. breaking of this trendline would be extremely bullish and picking some
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where LABS is featured.

Low-cap pot: Small cannabis companies
23 No. of Symbols
See all sparks
Related stocks
Frequently Asked Questions
The current price of LABS is 0.100 CAD — it hasn't changed in the past 24 hours. Watch MEDIPHARM LABS CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MEDIPHARM LABS CORP stocks are traded under the ticker LABS.
LABS reached its all-time high on May 14, 2019 with the price of 7.390 CAD, and its all-time low was 0.055 CAD and was reached on Jun 29, 2023. View more price dynamics on LABS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LABS stock is 0.00% volatile and has beta coefficient of 1.04. Track MEDIPHARM LABS CORP stock price on the chart and check out the list of the most volatile stocks — is MEDIPHARM LABS CORP there?
Yes, you can track MEDIPHARM LABS CORP financials in yearly and quarterly reports right on TradingView.
MEDIPHARM LABS CORP is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
LABS earnings for the last quarter are −0.0042 CAD per share, whereas the estimation was −0.0034 CAD resulting in a −23.53% surprise. The estimated earnings for the next quarter are −0.0036 CAD per share. See more details about MEDIPHARM LABS CORP earnings.
MEDIPHARM LABS CORP revenue for the last quarter amounts to 15.29 M CAD, despite the estimated figure of 10.90 M CAD. In the next quarter, revenue is expected to reach 10.54 M CAD.
LABS net income for the last quarter is −1.73 M CAD, while the quarter before that showed −2.77 M CAD of net income which accounts for 37.78% change. Track more MEDIPHARM LABS CORP financial stats to get the full picture.
No, LABS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 25, 2025, the company has 161 employees. See our rating of the largest employees — is MEDIPHARM LABS CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDIPHARM LABS CORP EBITDA is −7.70 M CAD, and current EBITDA margin is −21.70%. See more stats in MEDIPHARM LABS CORP financial statements.
Like other stocks, LABS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDIPHARM LABS CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDIPHARM LABS CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDIPHARM LABS CORP stock shows the buy signal. See more of MEDIPHARM LABS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.